Drug Shortage Report for GABAPENTIN
Report ID | 69781 |
Drug Identification Number | 02388200 |
Brand name | GABAPENTIN |
Common or Proper name | GABAPENTIN |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 600MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-01-28 |
Actual start date | 2019-01-28 |
Estimated end date | 2019-05-10 |
Actual end date | 2019-05-10 |
Shortage status | Resolved |
Updated date | 2019-05-13 |
Company comments | Temporarily unavailable |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-12-17 | English | Compare |